Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy

Human endogenous retrovirus-H long terminal repeat-associating 2 (HHLA2) is a newly emerging immune checkpoint that belongs to B7 family. HHLA2 has a co-stimulatory receptor transmembrane and immunoglobulin domain containing 2 (TMIGD2) and a newly discovered co-inhibitory receptor killer cell Ig-lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Honggang, Xu, Jian, Zhang, Xiaozhen, Liang, Tingbo, Bai, Xueli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035628/
https://www.ncbi.nlm.nih.gov/pubmed/35439678
http://dx.doi.org/10.1016/j.ebiom.2022.103987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035628/
https://www.ncbi.nlm.nih.gov/pubmed/35439678
http://dx.doi.org/10.1016/j.ebiom.2022.103987

Ejemplares similares